Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy: A study using impedance-pH monitoring

Digestive Diseases and Sciences

Volumn 56, Issue 4, 2011, Pages 1099-1106

  Frazzoni, Marzio ^a   Conigliaro, Rita ^a   Melotti, Gianluigi ^a  

^a Nuovo Ospedale S Agostino   (Italy)

Author keywords

Acid reflux; Gastroesophageal reflux disease; Laparoscopic Nissen fundoplication; Non acid reflux; Proton pump inhibitors; Reflux monitoring

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; AGED; ALKALINITY; ARTICLE; CONTROLLED STUDY; DIGESTIVE TRACT PARAMETERS; DISEASE ASSOCIATION; DRUG MEGADOSE; ESOPHAGUS MANOMETRY; FEMALE; GASTRIC PH MONITORING; GASTROESOPHAGEAL REFLUX; GASTROESOPHAGEAL REFLUX PARAMETER; HEARTBURN; HUMAN; IMPEDANCE; LAPAROSCOPIC FUNDOPLICATION; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUESTIONNAIRE; REMISSION; SCORING SYSTEM; STOMACH FUNDOPLICATION; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; ELECTRIC IMPEDANCE; ESOPHAGEAL PH MONITORING; FEMALE; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; LAPAROSCOPY; LARYNGOPHARYNGEAL REFLUX; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79955626248     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1381-4     Document Type: Article

References (39)

1. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005;100:190-200. (Pubitemid 41623288)
2. Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: Protonpump inhibitor failure in gastro-oesophageal reflux disease - where next? Aliment Pharmacol Ther. 2005;22:79-94.
3. Fass R, Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut. 2009;58:295-309.
4. Sifrim D, Holloway R, Silny J, et al. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology. 2001;120:1588-1598. (Pubitemid 32523478)
5. Vela M, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell DO. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: Effect of omeprazole. Gastroenterology. 2001;120:1599-1606. (Pubitemid 32523479)
6. Hirano I, Richter JE, The Practice Parameters Committee of the American College of Gastroenterology. ACG practice guidelines: Esophageal reflux testing. Am J Gastroenterol. 2007;102:668-685.
7. Zerbib F, Bruley Des Varannes S, Roman S, et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther. 2005;22:1011-1021. (Pubitemid 41634884)
8. Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: A multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006;55:1398-1402. (Pubitemid 44476780)
9. Zerbib F, Roman S, Ropert A, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: A study in patients off and on therapy. Am J Gastroenterol. 2006;101:1956-1963. (Pubitemid 44337616)
10. Bredenoord AG, Tutuian R, Smout AJPM, Castell DO. Technology review: Esophageal impedance monitoring. Am J Gastroenterol. 2006;101:1-8.
11. Castell DO. Reflux testing in the 21st century: Is there a role for pH only? Clin Gastroenterol Hepatol. 2008;6:840-841.
12. Pandolfino JE, Vela MF. Esophageal reflux monitoring. Gastrointest Endosc. 2009;69:917-930.
13. Frazzoni M, Grisendi A, Lanzani A, Melotti G, De Micheli E. Laparoscopic fundoplication versus lansoprazole for gastrooesophageal reflux disease. A pH-metric comparison. Dig Liver Dis. 2002;34:99-104.
14. Frazzoni M, Lonardo A, Grisendi A, et al. Are routine duodenal and antral biopsies useful in the management of "functional" dyspepsia? A diagnostic and therapeutic study. J Clin Gastroenterol. 1993;17:101-108.
15. Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring: Review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004;53:1024-1031. (Pubitemid 38824163)
16. Kahrilas PJ, Shaheen NJ, Vaezi MF. American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135:1392-1413.
17. Mainie I, Tutuian R, Agrawal A, Adams D, Castell DO. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg. 2006;93:1483-1487. (Pubitemid 44893649)
18. Broeders JA, Draaisma WA, Bredenoord AJ, et al. Oesophageal acid hypersensitivity is not a contraindication to Nissen fundoplication. Br J Surg. 2009;96:1023-1030.
19. Hemmink GJM, Bredenoord AJ, Weusten BLAM, Monkelbaan JF, Timmer R, Smout AJPM. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: "on" or "off" proton pump inhibitor? Am J Gastroenterol. 2008;103:2446-2453.
20. Frazzoni M, Savarino E, Manno M, et al. Reflux patterns in patients with short segment Barrett's oesophagus: A study using impedance-pH monitoring off and on proton pump inhibitor therapy. Aliment Pharmacol Ther. 2009;30:508-515.
21. Bredenoord AJ, Draaisma WA, Weusten BLAM, Gooszen HG, Smout AJPM. Mechanisms of acid, weakly acidic and gas reflux after anti-reflux surgery. Gut. 2008;57:161-166. (Pubitemid 351158040)
22. Zerbib F, Duriez A, Roman S, Capedont M, Mion F. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors. Gut. 2008;57:156-160. (Pubitemid 351158039)
23. Tutuian R, Vela MF, Hill EG, Mainie I, Agrawal A, Castell DO. Characteristic of symptomatic acid reflux episodes on acid suppressive therapy. Am J Gastroenterol. 2008;103:1090-1096. (Pubitemid 351677992)
24. Scheffer RCH, Samsom M, Hebbard GS, Gooszen HG. Effects of partial (Belsey Mark IV) and complete (Nissen) fundoplication on proximal gastric function and esophagogastric junction dynamics. Am J Gastroenterol. 2006;101:479-487. (Pubitemid 43340922)
25. Roberts NB. Review article: Human pepsins - their multiplicity, function and role in reflux disease. Aliment Pharmacol Ther. 2006;24(Suppl. 2):2-9. (Pubitemid 44267777)
26. Bredenoord AJ, Weusten BLAM, Curvers WL, Timmer R, Smout AJPM. Determinants of perception of heartburn and regurgitation. Gut. 2006;55:313-318. (Pubitemid 43268266)
27. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, The Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus. Am J Gastroenterol. 2006;101:1900-1920.
28. Agrawal A, Roberts J, Sharma N, Tutuian R, Vela M, Castell DO. Symptoms with acid and nonacid reflux may be produced by different mechanisms. Dis Esophagus. 2009;22:467-470.
29. Aanen MC, Bredenoord AJ, Numans ME, Samson M, Smout AJPM. Reproducibility of symptom association analysis in ambulatory reflux monitoring. Am J Gastroenterol. 2008;103:2200-2208.
30. Pritchett JM, Aslam M, Slaughter JC, Ness RM, Garrett CG, Vaezi MF. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol. 2009;7:743-748.
31. Spechler JS. Surgery for gastroesophageal reflux disease: Esophageal impedance to progress? Clin Gastroenterol Hepatol. 2009;7:1264-1265.
32. Shay S, Tutuian R, Sifrim D, et al. Twenty-four hour ambulatory simultaneous impedance and pH-monitoring: A multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol. 2004;99:1037-1043. (Pubitemid 38917805)
33. Zentilin P, Iiritano E, Dulbecco P, et al. Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Dig Liver Dis. 2006;38:226-232. (Pubitemid 44356183)
34. Hila A, Agrawal A, Castell DO. Combined multichannel intraluminal impedance and pH esophageal testing compared to pH alone for diagnosing both acid and weakly acidic gastroesophageal reflux. Clin Gastroenterol Hepatol. 2007;5:172-177. (Pubitemid 46216940)
35. Campos GM, Peters JH, DeMeester TR, et al. Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg. 1999;3:292-300.
36. Jackson PG, Gleiber MA, Askari R, Evans SR. Predictors of outcome in 100 consecutive laparoscopic antireflux procedures. Am J Surg. 2001;181:231-235. (Pubitemid 32480221)
37. Vakil N. Review article: The role of surgery in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2007;25:1365-1372. (Pubitemid 46848888)
38. Roman S, Poncet G, Serray I, Zerbib F, Boulez J, Mion F. Characterization of reflux events after fundoplication using combined impedance-pH recording. Br J Surg. 2007;94:48-52. (Pubitemid 46142731)
39. Draaisma WA, Rijnhart-de Jong HG, Broeders IAMJ, Smout AJPM, Furnee EJB, Gooszen HG. Five-year subjective and objective results of laparoscopic and conventional Nissen fundoplication: A randomized trial. Ann Surg. 2006;244:34-41. (Pubitemid 44297446)